NSIS_B fundamentals
An in-depth look to NOVONESIS (NOVOZYMES) A/S B operating, investing, and financing activities
NSIS_B free cash flow for Q4 23 is 634 M DKK. For 2023, NSIS_B free cash flow was 2.29 B DKK and operating cash flow was 4.15 B DKK.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: DKK
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM